clinical trial · NCT00446186
MK0476 Study in Adult Patients With Allergic Rhinitis (0476-378)
Organon and Co·phase2·completed·n = 945
Rhinitis AllergicMK0476, montelukast sodium / Duration of Treatment: 2 WeeksComparator: placebo / Duration of Treatment: 2 Weeks
brief summary
The clinical study evaluates the efficacy and safety of MK0476 in adult patients with allergic rhinitis.
started
Feb 1, 2004
primary completion
Mar 1, 2004
completion
Mar 1, 2004
last updated
Aug 15, 2024
official title
Mk0476 Phase II Dose Finding Study -Allergic Rhinitis-
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol